Ex-FDA Leaders Denounce Vaccine Safety Memo
A dozen former FDA commissioners have issued a scathing critique of internal claims doubting vaccine safety. Read their full statement and the potential impact on public health policy.
Category : Search result: Trump autism drug FDA leucovorin autism treatment pharmaceutical pressure
Study: Supplement Trio Reverses Autism Signs in Mice
A new study reveals a nutrient mixture of zinc, serine, and BCAAs reversed autism-like symptoms in mice, offering a promising new dietary therapy avenue for ASD. Could this lead to human treatments?
NHS Trump drug deal 'may cost 15,000 lives'
A £3bn deal to pay US drug firms more and avoid Trump's tariffs could lead to 15,971 extra deaths yearly as NHS rations care, York University research reveals. Read the full analysis.
UK's 25% US Drug Price Deal: A 'Problematic Precedent'
The UK's agreement to pay 25% more for new US medicines has sparked warnings it could set a dangerous precedent for Australia's Pharmaceutical Benefits Scheme. Experts fear global ripple effects.
UK-US agree zero tariff deal on pharmaceuticals
The UK and US have struck a deal to maintain 0% tariffs on medicines for three years, alongside NHS commitments to increase spending on new drugs. Discover the implications for patients and industry.
NHS drug costs to rise 25% in US trade deal
The NHS will pay 25% more for new medicines under a UK-US trade agreement, costing taxpayers £3bn. The deal secures zero tariffs for UK pharmaceutical exports to America. Discover the full impact.
New FDA-Approved Glasses Slow Child Myopia
A new type of lens, recently approved by the FDA, promises to slow nearsightedness in children by 70%. Learn how these innovative glasses work and who can benefit.
Urgent Recall for Cancer-Linked Cooking Pans
An urgent recall has been issued for thousands of cooking pans over significant lead contamination, linked to cancer and autism. Check your kitchen now.
Novo Nordisk Alzheimer's Drug Trial Fails
Novo Nordisk's major Alzheimer's drug trial fails to show significant benefit, dashing hopes for a fast-tracked treatment. Read the full analysis of this setback.
ADHD medication recalled over effectiveness issues
A popular generic ADHD medication is being recalled nationwide after tests showed it may not dissolve properly, failing to deliver the full dose. Patients urged to check their prescriptions.
FDA axes black box warnings on menopause HRT
US FDA removes severe warnings from over 20 menopause hormone treatments after evidence review. Discover how this impacts women's health options and treatment decisions.
Trump pledges to cut weight-loss drug prices
Former President Donald Trump vows to dramatically reduce prices of GLP-1 medications including Ozempic and Wegovy if re-elected, targeting pharmaceutical giants in latest healthcare pledge.
Trump Pressures Novo Nordisk Over Ozempic Pricing
Former President Donald Trump is reportedly pushing pharmaceutical giant Novo Nordisk for major Ozempic price cuts in a move that could transform diabetes and weight loss treatment accessibility in America.
Weight Loss Drug Showdown: Novo Nordisk vs Eli Lilly
The pharmaceutical weight loss market heats up as Novo Nordisk's blockbuster drugs Wegovy and Ozempic confront serious competition from Eli Lilly's Mounjaro, reshaping diabetes and obesity treatment landscapes.
Novo Nordisk cuts forecasts again amid drug competition
Danish pharmaceutical giant Novo Nordisk cuts sales and profit forecasts for second time amid intensifying competition in weight-loss drug market.
FDA Urgent Recall: Dangerous Medication Mix-Up
Urgent safety alert as mislabeled potassium chloride tablets distributed to UK pharmacies. Health officials warn potentially fatal consequences for patients with low potassium levels.
Big Pharma's Tax Breaks: Calls for Transparency Grow
Pharmaceutical giants face mounting pressure to justify massive tax incentives amid concerns over NHS funding and pandemic-era profit surges. Westminster demands clarity on whether public investment delivers fair returns.
Model denied NHS cancer treatment in postcode lottery
Former model Sian Thompson's perfect life unravels as NHS refuses revolutionary cancer drug available privately, exposing Britain's healthcare postcode lottery crisis.
US dental anaesthetic shortage forces treatment cancellations
American dental practices face treatment cancellations as FDA confirms ongoing shortage of local anaesthetics, with no immediate resolution in sight.
FDA Recalls Blood Pressure Drug Over Cancer Risk
Patients across the UK prescribed Prazosin for blood pressure or prostate issues face urgent medication recall after FDA discovers dangerous carcinogens in tablets. Multiple manufacturers affected.
Trump pressured FDA over autism drug approval
Exclusive investigation reveals Donald Trump's relentless pressure on FDA officials to fast-track leucovorin for autism treatment despite limited scientific evidence and expert warnings.
Blood Pressure Drug Recalled Over Contamination Fears
A critical safety alert has been issued for specific batches of Prazosin Hydrochloride tablets after potential contamination was discovered. Patients advised to check their medication immediately.
Novo Nordisk bids for obesity biotech Metsera, challenging Pfizer
Danish pharmaceutical giant Novo Nordisk enters bidding war with Pfizer for obesity biotech firm Metsera, signalling major shift in weight-loss treatment market competition.
UK patients face treatment delays in pharma pricing crisis
A bitter pricing dispute between the UK government and pharmaceutical companies threatens to delay vital new medicines for NHS patients, with industry leaders warning of an escalating crisis.
GSK chief warns UK drug pricing reforms threaten industry
Emma Walmsley warns that proposed NHS drug pricing reforms could devastate Britain's pharmaceutical industry and drive investment overseas in stark government warning.
Trump's Secret Handwritten Notes to Pence Revealed
Exclusive documents show Donald Trump's personal handwritten notes to Mike Pence during the January 6th Capitol riots, revealing unprecedented pressure campaign on his Vice President.
FDA approves revolutionary new menopause drug Lynkuet
American regulators approve first-of-its-kind non-hormonal treatment Lynkuet, offering new hope for millions of women suffering from debilitating menopausal symptoms.
Major Statin Recall: 140,000 Bottles Withdrawn
Urgent medication safety warning as cholesterol drug Atorvastatin faces massive recall over contamination fears. FDA investigation reveals critical manufacturing issues.
New Alzheimer's Drug Slows Brain Decline in Trial
A pioneering new treatment has demonstrated remarkable success in slowing memory loss and cognitive decline in Alzheimer's patients, offering fresh hope for millions affected by the devastating condition.
Novo Nordisk Board Exodus: Chairman & 6 Directors Depart
Danish pharmaceutical giant Novo Nordisk faces major leadership shakeup as chairman and six board members step down following unprecedented growth of weight-loss drug Wegovy.
Page 1 of 4